Delivery Order SPE2DB24D2205-SPE2DB25FEJBA
- Not listed
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp for IMBRUVICA 70 mg capsules (28-count) on August 28, 2025, with a completion date of September 19, 2025. This non-set-aside contract uses firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $7,575.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 70 mg capsules (28-count packaging) with a completion date of June 24, 2025. This non-set-aside, competitively awarded contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Imbruvica 140 mg capsules (90-count units) with a ceiling value of $8,116.87. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 12, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Imbruvica 140 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) under a firm fixed-price contract. This delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract utilizes a delivery order mechanism,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of IMBRUVICA 140 mg capsules (90-count units) with a ceiling value of $16,233.74. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $16,233.74 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on September 3, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price, competitively awarded delivery order was placed without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $48,701.22 to AmerisourceBergen Drug Corp for supply of Imbruvica 140 mg capsules (quantity: 90 units) with a completion date of October 10, 2025. This competitive award, issued on September 19, 2025, carries firm fixed pricing and contains no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,116.87 for 90 capsules of Imbruvica 140 mg on September 5, 2025, with completion scheduled for September 26, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location in Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a $8,116.87 delivery order award from the Defense Logistics Agency on September 10, 2025, for IMBRUVICA 140 mg capsules (90-count supply). The contract operates under firm fixed-price terms with an ultimate completion date of October 1, 2025, and was awarded competitively with no set-aside designation. This delivery order is a child contract issued against AmerisourceBergen's larger...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEJBADelivery Order
The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 70 mg capsules (28-count packaging) under a firm fixed price contract type. This delivery order, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is classified as a child contract, indicating it derives from a larger parent contract vehicle. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's sustained selection for such substantial contract vehicles underscores its capability to meet federal procurement requirements through open competition and deliver critical pharmaceutical products to support military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/25/25 |